Literature DB >> 16148708

Prevention of esophageal strictures in a caustic burn model using halofuginone, an inhibitor of collagen type I synthesis.

Dan Arbell1, Raphael Udassin, Benjamin Z Koplewitz, Meir Ohana, Olga Genina, Mark Pines, Arnon Nagler.   

Abstract

OBJECTIVE: Esophageal strictures caused by caustic injury continue to be a plaguing problem. Halofuginone (HF) has been proven to inhibit the formation of fibrosis in various animal models and human diseases. Its mechanism appears to be through the suppression of the production of collagen alpha1(I) and transforming growth factor-beta signaling pathway. We tried to assess whether HF would have an effect on the formation of strictures after inducing caustic esophageal.
MATERIALS AND METHODS: Esophageal injury was caused by injecting 25% NaOH to an isolated esophageal segment. Study group rats were treated with HF orally for 3 consecutive days before the injury and afterward. Control group rats received regular chow. The results were evaluated by upper gastrointestinal series (UGI) and through pathologic studies.
RESULTS: HF treatment resulted in marked improvement in the esophageal strictures. The UGI series showed esophageal patency of 73% (45%-100%) in the treated animals (n = 7) as compared with almost no patency, 11% (5-16%), in the controls (n = 4) (P = .018). The histologic examination showed significantly less stricture and scarring in the treated group. Whereas the ratio between the esophageal wall thickness to mucosal thickness was 2.34 +/- 0.23 in the study group, the control group had a ratio of 9.56 +/- 0.69 (P = .0044). Finally, whereas 86% of the study group survived, all the rats in the control group died by day 20.
CONCLUSIONS: HF modulated the wound healing reaction caused by caustic injury of the esophagus in a rat model, resulting in increased esophageal patency, reduction in esophageal wall thickness, and increased survival.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16148708     DOI: 10.1097/01.mlg.0000176551.09051.f2

Source DB:  PubMed          Journal:  Laryngoscope        ISSN: 0023-852X            Impact factor:   3.325


  7 in total

1.  Accurate esophageal volume of rats: an accurate gateway to esophageal burn studies.

Authors:  Fahrettin Yildiz; Nazif Zeybek; Alpaslan Terzi; Sacid Coban
Journal:  Pediatr Surg Int       Date:  2008-07-04       Impact factor: 1.827

2.  Efficacy of topical halofuginone in myringotomy patency.

Authors:  Taner Ozdemir; Hakan Cincik; Salim Dogru; I Engin Cekin; S Arif Ulubil; Atila Gungor
Journal:  Eur Arch Otorhinolaryngol       Date:  2010-06-24       Impact factor: 2.503

Review 3.  Halofuginone for fibrosis, regeneration and cancer in the gastrointestinal tract.

Authors:  Mark Pines
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

4.  Resveratrol attenuates inflammation and stricture formation in experimental caustic esophageal burns.

Authors:  S Uguralp; C Irsi; T Aksoy; A Bay Karabulut; H Kirimlioglu; B Mizrak
Journal:  Pediatr Surg Int       Date:  2008-02-19       Impact factor: 1.827

5.  Preliminary results of antiscarring therapy in the prevention of postendoscopic esophageal mucosectomy strictures.

Authors:  Yuhsin Wu; Steve J Schomisch; Cassandra Cipriano; Amitabh Chak; Richard H Lash; Jeffrey L Ponsky; Jeffrey M Marks
Journal:  Surg Endosc       Date:  2013-10-08       Impact factor: 4.584

6.  Halofuginone improves caustic-induced oxidative injury of esophagus in rats.

Authors:  Kıvılcım Karadeniz Cerit; Berna Karakoyun; Elif Bahadır; Meral Yüksel; Nurdan Bülbül; Feriha Ercan; E Tolga Dağlı; Berrak Ç Yeğen
Journal:  Esophagus       Date:  2017-10-14       Impact factor: 4.230

7.  Development of a model of benign esophageal stricture in rats: the optimal concentration of sodium hydroxide for stricture formation.

Authors:  Yuichi Okata; Chieko Hisamatsu; Tomomi Hasegawa; Eiji Nishijima; Yutaka Okita
Journal:  Pediatr Surg Int       Date:  2011-01       Impact factor: 1.827

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.